First Header Logo Second Header Logo

Connection

Patrick McNutt to Potassium Channel Blockers

This is a "connection" page, showing publications Patrick McNutt has written about Potassium Channel Blockers.
Connection Strength

0.902
  1. Vazquez-Cintron E, Machamer J, Ondeck C, Pagarigan K, Winner B, Bodner P, Kelly K, Pennington MR, McNutt P. Symptomatic treatment of botulism with a clinically approved small molecule. JCI Insight. 2020 01 30; 5(2).
    View in: PubMed
    Score: 0.741
  2. Bradford AB, Machamer JB, Russo TM, McNutt PM. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms. Toxicol Appl Pharmacol. 2018 02 15; 341:77-86.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.